JNJ vs CAH
By Alex · Tickerpine
Johnson & Johnson vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CAH |
|---|---|---|
| Price | $271.95 | $220.29 |
| Market cap | $655.37B | $51.01B |
| P/E ratio | 31.4 | 30.5 |
| ROE | 25.74% | — |
| Profit margin | 21.48% | 0.67% |
| Revenue growth | 6.60% | 5.80% |
| Dividend yield | 1.97% | 0.94% |
| Beta | 0.23 | 0.52 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CAH in plain English
- JNJ is the bigger company — about 12.8× the market cap of CAH.
- CAH is cheaper on earnings (P/E 30.5 vs 31.4).
- JNJ is growing revenue faster (7% vs 6%).
- JNJ has the higher dividend yield (1.97% vs 0.94%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.